Clinical Trial Update: Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update examining sequential or combination therapy in hepatitis B patients who remain suppressed on nucleoside or nucleotide an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Qin Ning | Conditions: Chronic Hepatitis b | Phase 4 | Status: UNKNOWN